US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

156.24

+7.394.96%

Volume:572.32K

Turnover:89.63M

Market Cap:503.79M

PE:- -

High:158.64

Open:153.69

Low:153.48

Close:148.85

52wk High:198.18

52wk Low:32.55

Shares:3.22M

Float Shares:3.22M

Volume Ratio:0.76

T/O Rate:17.75%

Dividend:1.34

Dividend Rate:0.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Roche Holding AG (RHHVF)

ABBISKO-B's Novel Drug ABSK061 Receives FDA Rare Pediatric Disease Designation for Bone Growth Disorder

Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061

Sigma Healthcare Ltd (S5YA) Gets a Hold from Macquarie

160 HEALTH Advances Deployment of "Digital Medical Staff" System and Explores Deeper AI Integration in Healthcare

QIAGEN Gets US FDA Clearance for Gastrointestinal Panels on Automated Syndromic Platform

MT Newswires Live

How Investors Are Reacting To American Healthcare REIT (AHR) Equity Raise And Higher 2026 Guidance

Simply Wall St.

A Look At Johnson & Johnson (JNJ) Valuation After New Multiple Myeloma FDA Approval

Simply Wall St.

Cross Country Healthcare Announces Key Executive Leadership Changes

IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification

Medical Properties Trust says HSA is fully current on rent

Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO) and Coherus Biosciences (CHRS)

Buy Rating on Opus Genetics Driven by Advancing Gene Therapy Pipeline, Near‑Term Clinical Catalysts, and Solid Cash Runway

Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and BioNTech SE (BNTX)

Dow Jones Top Company Headlines at 3 PM ET: Bill Ackman Details Plan to Take Hedge-Fund Firm, New Fund Public Simultaneously | FDA ...

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)

Sector Update: Health Care Stocks Mixed Tuesday Afternoon

MT Newswires Live

Analysts Are Bullish on Top Healthcare Stocks: Opus Genetics (IRD), ImageneBio (IMA)

Healthcare of Ontario Pension Plan earned a net return of 7.7 per cent for 2025

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":156.24,"timestamp":1773691200000,"preClose":148.85,"halted":0,"volume":572319,"delay":0,"changeRate":0.049647295935505646,"floatShares":3224486,"shares":3224486,"eps":0,"marketStatus":"Pre-Mkt","change":7.39,"latestTime":"03-17 05:14:20 EDT","open":153.69,"high":158.635,"low":153.48,"amount":89634112.19235,"amplitude":0.034632,"askPrice":155.59,"askSize":129,"bidPrice":152,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773754200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.24,"sharesOutstanding":3074486,"nav":149.06,"aum":480642683.13,"dividendRate":0.0086,"bidAskSpread":0.002274,"postHourTrading":{"tag":"盘后","latestPrice":155.6,"preClose":156.24,"latestTime":"19:59 EDT","volume":2842,"amount":443402.765,"timestamp":1773705575958,"change":-0.64,"changeRate":-0.004096,"amplitude":0.007531},"volumeRatio":0.7630840639562582,"impliedVol":1.0565,"impliedVolPercentile":0.896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7630840639562582,"shares":3224486,"dividePrice":1.3437,"high":158.635,"amplitude":0.034632,"preClose":148.85,"low":153.48,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":156.24,"committee":0.215805,"eps":0,"divideRate":0.0086,"volume":572319,"delay":0,"ttmEps":0,"open":153.69,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":169.89,"twentyDayClose":156.45,"sixtyDayClose":160.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618999802","title":"Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Roche Holding AG (RHHVF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618999802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618999802?lang=en_us&edition=fundamental","pubTime":"2026-03-11 10:00","pubTimestamp":1773194424,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IQVIA Holdings (IQV – Research Report) and Roche Hol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-iqvia-holdings-iqv-roche-holding-ag-rhhvf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-iqvia-holdings-iqv-roche-holding-ag-rhhvf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSX","LU0130517989.USD","LU0648001328.SGD","LU0980610538.SGD","RHHBY","BK4530","BK4007","LU0130102774.USD","XBI","LU1791710582.SGD","BK4112","LU0128526141.USD","LU0528227936.USD","LU0648000940.SGD","LU0882574055.USD","LU1201861165.SGD","LABU","BK4585","BK4588","IQV","BK4581","BK4137","BLSG","LU1989764664.SGD","BK4121","LU1791710400.SGD","LU0477156797.USD","LU0130103400.USD","LU0029874061.USD","LU1201861249.SGD","LU1261432733.SGD","LU1989764748.USD","LU0477156953.USD","LU0198837287.USD","BK4210","LU0130518102.USD"],"gpt_icon":0},{"id":"1165962320","title":"ABBISKO-B's Novel Drug ABSK061 Receives FDA Rare Pediatric Disease Designation for Bone Growth Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=1165962320","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165962320?lang=en_us&edition=fundamental","pubTime":"2026-03-11 08:18","pubTimestamp":1773188315,"startTime":"0","endTime":"0","summary":"ABBISKO-B (02256) announced that its subsidiary, Shanghai Abbisko Biomedical Technology Co., Ltd., has received Rare Pediatric Disease (RPD) designation from the U.S. Food and Drug Administration...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2476274308.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LABU","LU2488822045.USD","BK4585","LU2476274720.SGD","LU2778985437.USD","IE00BPRC5H50.USD","02256","BK4588"],"gpt_icon":0},{"id":"2618113998","title":"Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061","url":"https://stock-news.laohu8.com/highlight/detail?id=2618113998","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618113998?lang=en_us&edition=fundamental","pubTime":"2026-03-11 08:08","pubTimestamp":1773187712,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has issued an update. Abbisko Cayman Limited said its subsidiary Abbisko Therapeutics has secured U.S. FDA Ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-rare-pediatric-disease-status-for-achondroplasia-drug-absk061?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-rare-pediatric-disease-status-for-achondroplasia-drug-absk061?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"gpt_icon":0},{"id":"2618967776","title":"Sigma Healthcare Ltd (S5YA) Gets a Hold from Macquarie","url":"https://stock-news.laohu8.com/highlight/detail?id=2618967776","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618967776?lang=en_us&edition=fundamental","pubTime":"2026-03-11 07:06","pubTimestamp":1773184013,"startTime":"0","endTime":"0","summary":"Macquarie analyst maintained a Hold rating on Sigma Healthcare Ltd today and set a price target of A$3.20. In addition to Macquarie, Sigma Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-gets-a-hold-from-macquarie-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-gets-a-hold-from-macquarie-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4137","XBI","LU0128526141.USD","LU0029874061.USD","BK4588","BK4585","XLV","LABU"],"gpt_icon":0},{"id":"1179090818","title":"160 HEALTH Advances Deployment of \"Digital Medical Staff\" System and Explores Deeper AI Integration in Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=1179090818","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179090818?lang=en_us&edition=fundamental","pubTime":"2026-03-11 06:30","pubTimestamp":1773181823,"startTime":"0","endTime":"0","summary":"160 HEALTH (02656) has announced that the group is progressively implementing a \"Digital Medical Staff\" system for medical institutions, leveraging its integrated model of \"Platform + AI Agents +...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","02656","159760","LABU","BK4585","XBI","BK4581","BK4588","159819","159891","XLV"],"gpt_icon":0},{"id":"2618964401","title":"QIAGEN Gets US FDA Clearance for Gastrointestinal Panels on Automated Syndromic Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2618964401","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618964401?lang=en_us&edition=fundamental","pubTime":"2026-03-11 05:42","pubTimestamp":1773178952,"startTime":"0","endTime":"0","summary":"QIAGEN  said late Tuesday it has received clearance from the US Food and Drug Administration for the use of its gastrointestinal panels on the QIAstat-Dx Rise automated syndromic testing system.Following the health regulator's approval, laboratories in the US can run respiratory and gastrointestinal panels on the higher-throughput automated platform, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1923622614.USD","BK4121","BK4588","QGEN","LABU","LU2125909247.SGD","LU2433249047.HKD","BK4585","LU2125909593.SGD"],"gpt_icon":0},{"id":"2618962458","title":"How Investors Are Reacting To American Healthcare REIT (AHR) Equity Raise And Higher 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2618962458","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618962458?lang=en_us&edition=fundamental","pubTime":"2026-03-11 05:22","pubTimestamp":1773177760,"startTime":"0","endTime":"0","summary":"In late February 2026, American Healthcare REIT, Inc. completed an at-the-market follow-on equity offering raising about US$769.86 million across multiple common stock tranches and reported fourth-quarter 2025 results showing revenue of US$604.08 million and net income of US$10.78 million.\nThe company also issued 2026 guidance calling for higher net income and same-store net operating income growth, while quarterly real estate impairment charges fell sharply year-on-year to US$11.80 million,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-ahr/american-healthcare-reit/news/how-investors-are-reacting-to-american-healthcare-reit-ahr-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-ahr/american-healthcare-reit/news/how-investors-are-reacting-to-american-healthcare-reit-ahr-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["8C8U.SI","BK4588","BK4215","ISBC","LABU","REIT","XLV","BK4585","BK6142","CFA.SI","AHR","EQR","XBI","BK4211","BK4225","BK4581"],"gpt_icon":0},{"id":"2618962498","title":"A Look At Johnson & Johnson (JNJ) Valuation After New Multiple Myeloma FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2618962498","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618962498?lang=en_us&edition=fundamental","pubTime":"2026-03-11 05:21","pubTimestamp":1773177674,"startTime":"0","endTime":"0","summary":"Johnson & Johnson (JNJ) just secured U.S. FDA approval for TECVAYLI plus DARZALEX FASPRO in adults with relapsed or refractory multiple myeloma after at least one prior therapy, reshaping attention on the stock’s drug pipeline.\nSee our latest analysis for Johnson & Johnson.\nThe FDA approval comes after a run of pipeline updates in oncology and autoimmune diseases, while Johnson & Johnson also faces ongoing talc and antitrust litigation in North America that keeps legal risk in focus alongside...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/a-look-at-johnson-johnson-jnj-valuation-after-new-multiple-m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/a-look-at-johnson-johnson-jnj-valuation-after-new-multiple-m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0345770993.USD","BK4532","LU1244550577.SGD","LU1032955483.USD","LU1074936037.SGD","LU1196500208.SGD","LU0432979614.USD","IE00BVYPNV92.GBP","LU0234572021.USD","LU2129689431.USD","IE00BJT1NW94.SGD","LU0345769128.USD","LU1674673428.USD","LU2471134879.HKD","LU0114720955.EUR","IE00BDGV0183.EUR","LU1778281490.HKD","LU2592432038.USD","LU2750360997.AUD","LU1585245621.USD","LU0203345920.USD","BK4534","LU2602419157.SGD","LU2089984988.USD","BK4504","LABU","LU1061106388.HKD","IE0002270589.USD","LU1894683264.USD","LU0985320562.USD","LU0792757196.USD","BK4533","IE00BBT3K403.USD","LU2505996681.GBP","IE00BZ1G4Q59.USD","LU0124676726.USD","SG9999002232.USD","IE00BKVL7J92.USD","LU1057294990.SGD","IE0034235303.USD","LU1732800096.USD","IE00BLSP4239.USD","LU1059921491.USD","LU1674673691.USD","BK4559","LU2471134523.USD","IE00BN8TJ469.HKD","IE00B3PB1722.GBP","JNJ","LU2347655156.SGD"],"gpt_icon":0},{"id":"2618809961","title":"Cross Country Healthcare Announces Key Executive Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2618809961","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618809961?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:30","pubTimestamp":1773174657,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Cross Country Healthcare ( ($CCRN) ). Cross Country Healthcare, Inc. announced that, effective March 10, 2026, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcare-announces-key-executive-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cross-country-healthcare-announces-key-executive-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4196","XLV","XBI","CCRN","BK4585","BK4581"],"gpt_icon":0},{"id":"2618629969","title":"IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification","url":"https://stock-news.laohu8.com/highlight/detail?id=2618629969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618629969?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:22","pubTimestamp":1773174145,"startTime":"0","endTime":"0","summary":"Healthcare is diverse sector of the economy.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ihi-ihe-arkg-specialty-healthcare-etfs-offer-portfolio-diversification?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ihi-ihe-arkg-specialty-healthcare-etfs-offer-portfolio-diversification?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4544","LU0029874061.USD","XBI","BK4588","IHE","LABU","XLV","ARKG","BK4581","HCSG","BK4137","IHI","BK4585"],"gpt_icon":0},{"id":"2618969626","title":"Medical Properties Trust says HSA is fully current on rent","url":"https://stock-news.laohu8.com/highlight/detail?id=2618969626","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618969626?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:11","pubTimestamp":1773173516,"startTime":"0","endTime":"0","summary":"Medical Properties Trust (MPT) issued the following statement regarding litigation involving Healthcare Systems of America, or HSA: “We are aware t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medical-properties-trust-says-hsa-is-fully-current-on-rent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medical-properties-trust-says-hsa-is-fully-current-on-rent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","MPT","BK4225","LABU","XBI","XLV"],"gpt_icon":0},{"id":"2618955969","title":"Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO) and Coherus Biosciences (CHRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618955969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618955969?lang=en_us&edition=fundamental","pubTime":"2026-03-11 04:10","pubTimestamp":1773173406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evotec AG (EVO – Research Report) and Coherus Biosci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-evotec-ag-evo-and-coherus-biosciences-chrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-evotec-ag-evo-and-coherus-biosciences-chrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","EVO","LU0128526141.USD","LU0029874061.USD","BK4585","BK4588","CHRS","XLV","LABU","BK4139","AG","BK4581","XBI","BK4535","BK4121","BK4137","BK4210"],"gpt_icon":0},{"id":"2618669409","title":"Buy Rating on Opus Genetics Driven by Advancing Gene Therapy Pipeline, Near‑Term Clinical Catalysts, and Solid Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2618669409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618669409?lang=en_us&edition=fundamental","pubTime":"2026-03-11 03:45","pubTimestamp":1773171923,"startTime":"0","endTime":"0","summary":"Opus Genetics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Capital reitera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-opus-genetics-driven-by-advancing-gene-therapy-pipeline-near‑term-clinical-catalysts-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-opus-genetics-driven-by-advancing-gene-therapy-pipeline-near‑term-clinical-catalysts-and-solid-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","XBI","XLV","LABU","BK4588"],"gpt_icon":0},{"id":"2618965182","title":"Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618965182","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618965182?lang=en_us&edition=fundamental","pubTime":"2026-03-11 03:10","pubTimestamp":1773169804,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS – Research Report) and Bio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-senseonics-holdings-sens-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-senseonics-holdings-sens-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","LU0128526141.USD","BK4585","LU0029874061.USD","BK4082","XLV","BK4588","BK4551","LABU","BK4535","BK4548","BK4137","SENS","HCSG","XBI","BK4581","BK4139","BNTX"],"gpt_icon":0},{"id":"2618719963","title":"Dow Jones Top Company Headlines at 3 PM ET: Bill Ackman Details Plan to Take Hedge-Fund Firm, New Fund Public Simultaneously | FDA ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2618719963","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618719963?lang=en_us&edition=fundamental","pubTime":"2026-03-11 03:00","pubTimestamp":1773169200,"startTime":"0","endTime":"0","summary":"Bill Ackman Details Plan to Take Hedge-Fund Firm, New Fund Public Simultaneously. The billionaire investor's unique double listing is an attempted do-over of a botched 2024 offering of the new investment fund.FDA Warns Novo Nordisk of Unreported Side Effects Tied to GLP-1 Patients. The FDA underscored cases including two deaths and a suicide linked to patients taking semaglutide, which Novo markets as Ozempic and Wegovy.Meta to Acquire AI-Only Social Media Platform Moltbook. Moltbook's team will join Meta's Superintelligence Labs division in the tech giant's latest move to scale up its AI-related talent and capabilities.Former Meta AI Pioneer Yann LeCun Raises Over $1 Billion for New Startup. Advanced Machine Intelligence seeks to develop a new breed of AI systems that can better understand the real world than existing models.Boeing Says Wiring Flaws Will Slow Some 737 MAX Deliveries. Exxon Mobil Plans to Move Its Legal Home to Texas From New Jersey. CEO Michael Bender said the departm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ET","LABU","BK4581","BK4561","BK4590","BK4585","BK4588","BK4144"],"gpt_icon":0},{"id":"2618968076","title":"Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Veeva Systems (VEEV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618968076","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618968076?lang=en_us&edition=fundamental","pubTime":"2026-03-11 02:20","pubTimestamp":1773166807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tyra Bioscience (TYRA – Research Report) and Veeva S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-tyra-bioscience-tyra-veeva-systems-veev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-tyra-bioscience-tyra-veeva-systems-veev-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4112","BK4137","BK4534","XBI","BK4581","LU0266013472.USD","TYRA","BLSG","BLSX","BK4613","LABU","BK4139","LU0029874061.USD","LU1989764664.SGD","VEEV","BK4585","BK4588","LU0170899867.USD","BK4167","LU0128526141.USD","LU1989764748.USD","LU0289739699.SGD","BK4504","BK4528","LU0058720904.USD"],"gpt_icon":0},{"id":"2618968597","title":"Sector Update: Health Care Stocks Mixed Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2618968597","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618968597?lang=en_us&edition=fundamental","pubTime":"2026-03-11 01:56","pubTimestamp":1773165383,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Tuesday afternoon, with the NYSE Health Care Index shedding 0.2% and the State Street Health Care Select Sector SPDR ETF  fractionally higher.The iShares Biotechnology ETF  climbed 1.2%.In corporate news, BioNTech's  co-founders plan to leave the German drugmaker to establish a new independent company focused on messenger ribonucleic acid, or mRNA, technologies, while the firm provided a full-year revenue outlook below market expectations. Its shares dropped 20%.Novo Nordisk  said Tuesday it received a warning letter from the US Food and Drug Administration on March 5 related to a Post-marketing Adverse Drug Experience inspection conducted in early 2025 at its Plainsboro, New Jersey site. Novo shares fell 3%.Capricor Therapeutics  shares jumped 10% after it said Tuesday the US Food and Drug Administration has lifted its previously issued Complete Response Letter and resumed review of the biologics license application for Deramiocel, a potential treatment f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4532","NVO","LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","NVOX","BK4588","BK4551","IE00BZ1G4Q59.USD","BK4007","LU1093756168.USD","CAPR","BK7104","LABU","XBI","BK4585","BK4599","LU0154236417.USD","BK4581","BK4568","BK4535","BK4139","BNTX"],"gpt_icon":1},{"id":"2618968909","title":"Analysts Are Bullish on Top Healthcare Stocks: Opus Genetics (IRD), ImageneBio (IMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618968909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618968909?lang=en_us&edition=fundamental","pubTime":"2026-03-11 01:50","pubTimestamp":1773165009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Opus Genetics (IRD – Research Report) and ImageneBio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-opus-genetics-ird-imagenebio-ima-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-opus-genetics-ird-imagenebio-ima-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4112","BK4007","LU0029874061.USD","BK4581","XBI","IRD","BK4588","BLSG","BK4137","BK4585","LABU","BK4139","BLSX","IMA"],"gpt_icon":0},{"id":"2618637968","title":"Healthcare of Ontario Pension Plan earned a net return of 7.7 per cent for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2618637968","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618637968?lang=en_us&edition=fundamental","pubTime":"2026-03-11 01:39","pubTimestamp":1773164340,"startTime":"0","endTime":"0","summary":"The Healthcare of Ontario Pension Plan earned a net return of 7.7 per cent for 2025.","market":"sg","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/ZXZ47CV5FCXQOBPANLDKXFZ72U.jpg?smart=true&auth=a60dbec641dd9a541dbed40e7008a20f63947d90dcf25eb53cb48ab2c82428d9&width=500&height=333","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/ZXZ47CV5FCXQOBPANLDKXFZ72U.jpg?smart=true&auth=a60dbec641dd9a541dbed40e7008a20f63947d90dcf25eb53cb48ab2c82428d9&width=500&height=333"],"rights":{"source":"bnn_bloomberg_highlight","url":"https://www.bnnbloomberg.ca/business/2026/03/10/healthcare-of-ontario-pension-plan-earned-a-net-return-of-77-per-cent-for-2025/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/business/2026/03/10/healthcare-of-ontario-pension-plan-earned-a-net-return-of-77-per-cent-for-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["HCSG","BK4585","LU0128526141.USD","XBI","BK4581","LU0029874061.USD","BK4588","BK4137","LABU","XLV"],"gpt_icon":0},{"id":"2618203957","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618203957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618203957?lang=en_us&edition=fundamental","pubTime":"2026-03-11 00:50","pubTimestamp":1773161405,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TriSalus Life Sciences (TLSI – Research Report), Cullinan Managem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-cullinan-management-cgem-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-cullinan-management-cgem-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.USD","LU1023059063.AUD","IE000M9KFDE8.USD","BK4581","LU1057294990.SGD","SG9999002224.SGD","SG9999013999.USD","LU0234572021.USD","BK4585","BK4137","LU0321505868.SGD","SG9999011175.SGD","BK4588","SG9999003800.SGD","LU0058720904.USD","LU1066051498.USD","LU0225284248.USD","IE00B19Z3B42.SGD","TLSI","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4139","BK4533","BK4592","LU0306806265.USD","LU1066053197.SGD","SG9999002232.USD","LU1883839398.USD","LU0122379950.USD","BK4568","LABU","LU0225771236.USD","LU0868494617.USD","SG9999001176.SGD","LU0306807586.USD","LU0128526141.USD","CGEM","LU0456855351.SGD","BK4599","IE00BBT3K403.USD","LU0029874061.USD","SGXZ57979304.SGD","LU1894683348.USD","LU1894683264.USD","IE0002270589.USD","LU0289739699.SGD","LU0985481810.HKD","BK4550","PFE","XBI","BK4534","BK4007","LU0321505439.SGD","IE00B19Z3581.USD","LU0170899867.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":9,"totalSize":416,"code":"91000000","status":"200"}]}}